Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS

Hemodialysis International

Volumn 20, Issue 1, 2016, Pages 38-49

  Fissell, Rachel B ^a   Karaboyas, Angelo ^b   Bieber, Brian A ^b   Sen, Ananda ^c   Li, Yun ^b,c   Lopes, Antonio A ^d   Akiba, Takashi ^e   Bommer, Jürgen ^f   Ethier, Jean ^g   Jadoul, Michel ^h   Pisoni, Ronald L ^b   Robinson, Bruce M ^b,c   Tentori, Francesca ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f Dialysezentrum Heidelberg   (Germany)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Adherence; Mineral bone disorder; Phosphate binders; Pill burden

Indexed keywords

BIOLOGICAL MARKER; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; MINERAL; PHOSPHATE;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; ATTITUDE TO ILLNESS; BEHAVIOR ASSESSMENT; BELGIUM; BLOOD LEVEL; BONE DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DIALYSIS OUTCOME AND PRACTICE PATTERN STUDY; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT ASSESSMENT; PATIENT ATTITUDE; PILL BURDEN; PRESCRIPTION; SELF REPORT; SOCIAL INTERACTION; TREATMENT REFUSAL; UNITED STATES; ADVERSE EFFECTS; AGED; BLOOD; COHORT ANALYSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PROSPECTIVE STUDY; PSYCHOLOGY;

AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PHOSPHATES; PHOSPHORUS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 84956584253     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12315     Document Type: Article

References (38)

1. Goodkin DA, Young EW, Kurokawa K, Prutz K, Levin N. Mortality among hemodialysis patients in Europe, Japan, and the United States: Case-mix effects. Am J Kidney Dis. 2004; 44(S2):S16-S21.
2. Lowrie EG, Lew N. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990; 15:458-482.
3. Kalpakian MA, Mehrotra R. Vascular calcification and disordered mineral metabolism in dialysis patients. Semin Dial. 2007; 20:139-143.
4. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis. 1998; 31:607-617.
5. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study. J Am Soc Nephrol. 2005; 16:1788-1793.
6. Tentori F, Blayney MJ, Albert JM, etal. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008; 52:519-530.
7. Giachelli CM. Vascular calcification: In vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol. 2003; 14:S300-S304.
8. Jono S, McKee MD, Murry CE, etal. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000; 87:E10-E17.
9. Di Marco GS, Konig M, Stock C, etal. High phosphate directly affects endothelial function by downregulating annexin II. Kidney Int. 2013; 83:213-222.
10. Isakova T, Gutierrez OM, Chang Y, etal. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol. 2009; 20:388-396.
11. Lopes A, Tong L, Thumma J, etal. Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Evaluation of possible confounding by nutritional status. Am J Kidney Dis. 2012; 60:90-101.
12. Young EW, Albert JM, Satayathum S, etal. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005; 67:1179-1187.
13. Curtin RB, Svarstad BL, Keller TH. Hemodialysis patients' noncompliance with oral medications. ANNA J. 1999; 26:307-316.
14. The USRDS dialysis morbidity and mortality study: Wave 2. United States renal data system. Am J Kidney Dis. 1997; 30:S67-S85.
15. Manley HJ, Garvin CG, Drayer DK, etal. Medication prescribing patterns in ambulatory haemodialysis patients: Comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant. 2004; 19:1842-1848.
16. Chiu Y, Teitelbaum I, Misra M, Marie de Leon E, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009; 4:1089-1096.
17. Ingersol KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: A review of the literature. J Behav Med. 2008; 31:213-224.
18. Young EW, Goodkin DA, Mapes DL, etal. The Dialysis Outcomes and Practice Patterns Study: An international hemodialysis study. Kidney Int. 2000; 57:S74-S81.
19. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA. The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology. Am J Kidney Dis. 2004; 44(Suppl 2):7-15.
20. Van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999; 18:681-694.
21. Raghunathan TE, Solenberger PW, Van Hoewyk J. IVEware: Imputation and Variance Estimation Software: User Guide. Ann Arbor, MI: Institute for Social Research, University of Michigan. 2002.
22. Little RJA, Rubin DB. Statistical Analysis with Missing Data. New York, Wiley; 1987.
23. Saran R, Bragg-Gresham JL, Rayner HC, etal. Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003; 64:254-262.
24. Blanchard R, Berger W, Bailie GR, Eisele G. Knowledge of hemodialysis and CAPD patients about their prescribed medicines. Clin Nephrol. 1990; 34:173-178.
25. Chater AM, Parham R, Riley S, Hutchison AJ, Horne R. Profiling patient attitudes to phosphate binding medication: A route to personalizing treatment and adherence support. Psychol Health. 2014; 29:1407-1420.
26. Schlebusch L, Levin A. Psychotherapeutic management of good and poor compliance in haemodialysis. S Afr Med J. 1982; 16:92-94.
27. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001; 23:1296-1310.
28. Wang S, Alfieri T, Ramakrishnan K, Braunhofer P, Newsome BA. Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis. Nephrol Dial Transplant. 2014; 29:2092-2099.
29. Fischer D, Cline K, Plone MA, Dillon M, Burke SK, Blair AT. Results of a randomized crossover study comparing once-daily then thrice-daily sevelamer dosing. Am J Kidney Dis. 2006; 48:437-444.
30. Toussaint ND, Pedagogos E, Beavis J, Becker GJ, Polkinghorne KR, Kerr PG. Improving CKD-MBD management in haemodialysis patients: Barrier analysis for implementing better practice. Nephrol Dial Transplant. 2011; 26:1319-1326.
31. Campbell KL, Ash S, Zabel R, McFarlane C, Juffs P, Bauer JD. Implementation of standardized nutrition guidelines by renal dietitians is associated with improved nutrition status. J Ren Nutr. 2009; 19:136-144.
32. USRDS. Atlas of CKD and ESRD. Volume 2, Chapter 6-Prescription Drug Coverage, 2012, p. 280. Available from: http://www.usrds.org/atlas.aspx (accessed date: March 19, 2013).
33. Feldman RL, Desmarais MP, Muller JS. Orals in the bundle: A policy framework. Clin J Am Soc Nephrol. 2013; 8:1043-1047.
34. Department of Health and Human Services. Centers for Medicare & Medicaid Services. 42 CFR Parts 413 and 417. Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for all medicare providers. Final rule. Fed Regist. 2012; 77:67450-67531.
35. 2012 Annual Report of the Dialysis Outcomes and Practice Patterns Study: Hemodialysis Data 1997-2011. Arbor Research Collaborative for Health, Ann Arbor, MI. Available at dopps.org/annualreport/ (accessed date: May 1, 2015).
36. Mark SJ. Hyperparathyroid and hypoparathyroid disorders. NEJM. 2000; 343:1863-1875.
37. King KB, Reis HT. Marriage and long-term survival after coronary artery bypass grafting. Health Psychol. 2012; 31:55-62.
38. Tentori F, Wang M, Bieber B, etal. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: The DOPPS study. Clin J Am Soc Nephrol. 2015; 10:98-109.